Alan Peter Lewis

Title: Alan Peter Lewis: Innovator in Antibody Production

Introduction: Alan Peter Lewis, an accomplished inventor based in Beckenham, GB, has made significant contributions to the field of biotechnology. With a total of two patents to his name, Lewis has focused his efforts on pioneering advancements in antibody production.

Latest Patents: Alan Peter Lewis holds two notable patents. The first pertains to the "Production of antibodies," which involves the preparation of recombinant primate antibodies using DNA technology. This invention encompasses micro-RNA techniques for production, along with formulations containing recombinant non-human primate antibodies. These antibodies have important implications for the prophylaxis and treatment of humans, as well as for diagnostic uses. His second patent involves the "Preparation of chimaeric antibodies using the recombinant PCR strategy," further showcasing his dedication to innovative solutions in antibody technology.

Career Highlights: Lewis is currently employed at Glaxo Wellcome Inc., a prominent name in the pharmaceutical industry. His work at this company emphasizes his commitment to advancing medical science through his inventions and collaborative efforts in research.

Collaborations: Throughout his career, Alan Peter Lewis has collaborated with notable individuals, including James Scott Crowe. Their partnership highlights the importance of teamwork in the pursuit of groundbreaking innovations in the field of biotechnology.

Conclusion: Alan Peter Lewis exemplifies the spirit of innovation through his contributions to the development of antibody production techniques. His patents not only propel the scientific community forward but also demonstrate the potential for new therapies in medicine. Lewis's work at Glaxo Wellcome Inc. and his collaborations with fellow researchers define a successful career committed to making a difference in healthcare.